Mylab leverages Qure.ai's tech to enhance TB screening

Mylab leverages Qure.ai’s tech to enhance TB screening

Indian biotech company Mylab Discovery Solutions is integrating Qure.ai’s AI technology into its upcoming x-ray device for screening tuberculosis.According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai’s deep-learning software qXR to analyse chest x-ray images and identify TB within a minute. 
WHY IT MATTERS
India is one of the biggest contributors to global TB cases, accounting for 26% of the total global count and 34% of all TB deaths.
By leveraging technological innovation, both Mylab and Qure.ai aim to support the Indian government’s goal of eliminating TB by 2025. Their integrated…

Continue Reading
Morning Headlines 2/16/23

Morning Headlines 2/16/23

February 15, 2023 Headlines No Comments CPSI Announces Fourth Quarter and Full Year 2022 Results
CPSI reports Q4 results: revenue up 12%, adjusted EPS $0.61 versus $0.58, beating analyst expectations for both.
Cyber attack exposes personal data of approximately 1 million Community Health Systems patients
Hospital management company Community Health Systems (TN) begins notifying patients of a cyberattack on its third-party cybersecurity vendor Fortra, which may have exposed patient information.
CommonSpirit Health Releases FY2023 Q2 Financial Results
CommonSpirit Health reports a $474 million Q2 operating loss, some of which it attributes to the October ransomware attack that took its systems offline for nearly a…

Continue Reading
Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings

Blood Biotech Grifols Cuts Deep in the U.S. to Find €400M in Savings

Grifols, a company that turns blood plasma into therapies for immunological disorders and other conditions, is laying off about 2,000 U.S. workers as part of a corporate restructuring projected to yield up to €400 million in annual cost savings, the biotech announced Wednesday.
The layoffs represent about 8% of the Barcelona-based company’s global workforce, but they will happen mainly in its U.S. plasma operations. That’s notable because as a company that relies on plasma, the U.S. is vital to its business. The starting point for Grifols’s therapies is blood plasma. Key to its drug-making process is fractionation, in which the protein components…

Continue Reading
BCBS Tennessee Unveils Health Disparities in First Health Equity Report

BCBS Tennessee Unveils Health Disparities in First Health Equity Report

BlueCross BlueShield of Tennessee unveiled its first Health Equity Report Tuesday, which analyzed six topics of health disparities: behavioral health, cancer, child and adolescent care, chronic condition management, Covid-19 and maternal health.
The report serves as a way to understand the inequities that exist among its members to determine ways the payer can address the disparities, said Dr. Andrea Willis, chief medical officer of BCBS Tennessee. “We wanted to get a better picture of the health issues and barriers to care faced by our members and Tennesseans as a whole, so that we could more effectively partner with health care providers to…

Continue Reading
The Federal Trade Commission Accuses GoodRx Of Multiple Data Sharing Fails, Demands It Pay $1.5 Million Fine and Make Reforms

The Federal Trade Commission Accuses GoodRx Of Multiple Data Sharing Fails, Demands It Pay $1.5 Million Fine and Make Reforms

The Federal Trade Commission has cited telehealth and prescription drug discount provider GoodRx for sharing sensitive consumer health data with several advertising platforms, in violation of its own privacy promises to consumers.
The agency has filed a proposed order demanding that GoodRx pay $1.5 million in civil penalties for failing to let consumers know about unauthorized disclosures of its data to a list of advertiser platforms. including Facebook and Google.
The company, which is based in California, operates a digital health platform offering prescription drug discounts, telehealth visits and other health services. It captures a wide range of data from consumers who use…

Continue Reading
Effective Remote Teams: How to Lead Yourself and Your Team to Achieve Extraordinary Outcomes Without Burnout

Effective Remote Teams: How to Lead Yourself and Your Team to Achieve Extraordinary Outcomes Without Burnout

Tina Paterson the author of the new book Effective Remote Teams joins eHealth Radio and the Health News Channel. Tina has helped teams of over 10,000 members navigate working remotely while maintaining a healthy work/life balance.
Listen to interview with host Eric Michaels and guest Tina Paterson discuss the following:
How is it possible to leverage a virtual team and not only meet your goals but to outperform them without burnout?
It’s said that remote working can actually lead to over-productivity which can be a very fast way to lead to burnout. What can leaders do to help foster a culture of not…

Continue Reading
‘A Better Long-Term Solution’: How Health Systems Keep Workloads in the Cloud Secure

‘A Better Long-Term Solution’: How Health Systems Keep Workloads in the Cloud Secure

The evaluation process covers ­everything from compatibility to cost and the quality of customer service, but it also includes a comprehensive risk assessment led by the health system’s CISO.“Any vendor we’re potentially going to use must go through that assessment,” Meadows says. “We ask them about everything — their security infrastructure, their policy and procedure management, how they segment their networks — and then, based on their response, we can determine whether they’re a good fit or not.”
Cook Children’s also relies on a third-party system that allows it to check whether a particular vendor has experienced significant security issues in the…

Continue Reading
HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

The U.S. Department of Health & Human Services (HHS) unveiled three new models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models include access to $2 generic drugs.
The news is in response to President Joe Biden’s executive order issued in October, which directed HHS to find ways to lower prescription drug costs and improve access to drug therapies for those enrolled in Medicare and Medicaid health plans. The models are meant to build on the Inflation Reduction Act of 2022, which includes allowing Medicare to negotiate lower prescription drug prices for…

Continue Reading
Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device

Heartpoint Global Hopes To Disrupt Congenital Pulmonary Hypertension Treatment With Minimally Invasive Device

To correct high blood pressure of the pulmonary artery, which can arise from congenital defects of the heart, an artificial heart ucan cost upwards of $190,000. Heart disease accounted for about one in five deaths in 2020 in theUnited States.
Even minimally invasive pulmonary artery banding — a surgical technique that has been in use since Harry Truman was president — requires access to the chest cavity. A new treatment under development by HeartPoint Global seeks to provide a minimally invasive alternative to current treatments for pulmonary arterial hypertension associated with Congenital Heart Disease.A device delivered through the leg would cost only…

Continue Reading